Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Deciphex decodes $2.6m
Based at DCU Invent, Deciphex has gained investors including Inova and GI Partners as it looks to refine its offering for the toxicologic and gastrointestinal segments of pathology.
Oxford Brain Diagnostics secures funding
Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.
Mind Foundry discerns Parkwalk funding
The follow-on investment complements $1.7m raised by Oxford data analytics spinout Mind Foundry in 2016 from investors including Oxford Sciences Innovation.
Oxford spinouts score $61m in first quarter
The total raised by Oxford’s spinouts was down from $229m year-on-year, though university tech transfer office OUI also marked its largest ever single exit during the period.
Christou departs CIC
Victor Christou has stepped down from his position as chief executive of Cambridge Innovation Capital just weeks after helping the unit raise $196m in additional funding.
Gyroscope enters Orbit for merger
Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.
Cytora assesses $32.6m series B
Cambridge Innovation Capital and Parkwalk Advisors have both returned to back a $32.6m series B round for Cytora, an insurance technology spinout of Cambridge.
Metry measures $1.5m investment
Chalmers Ventures has contributed to a $1.5m funding round for cleantech developer Metry.

Other News

Boehringer Ingelheim regenerates Agomab
Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer spun out of University of Turin.
Chalmers Ventures strengthens team
Jonas Bergman, Rocio Morales and Nina Röding have joined Chalmers Ventures, the investment and incubator arm of Chalmers University of Technology.
OUI appoints trio to board
Lindsay Pearson, Adam Stoten and Liam Dolen have been appointed to Oxford University Innovation's board following the departures of Nicola Blackwood and Giles Kerr.
Sano Genetics matches up $650,000
Cambridge Enterprise joined Seedcamp and private investors for Sano Genetics’ seed round, proceeds of which will support the company’s data-sharing platform for genomic research.
Aqdot emulsifies $7.8m series B
Cambridge-founded chemicals products maker Aqdot has welcomed the return of IP Group and Parkwalk Advisors in its latest round, taking its funding total to $16.5m.
Avectas collects $10m
NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg